MEDICO REMEDIES LIMITED
MEDICO · General/Diversified · NSE
₹41
Current Market Price
Fair Value (DCF)
₹20
Margin of Safety
-51.5%
Updated 1d ago
YieldIQ Score
42/100
Piotroski F-Score
5/9
Economic Moat
Moderate
Confidence
59%
ROE
—
Debt/Equity
0.19
WACC
11.1%
Market Cap
₹339 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
22.9%
Return on capital employed
EV / EBITDA
22.0×
Enterprise multiple
Debt / EBITDA
0.9×
Leverage vs earnings
Interest Coverage
16.9×
EBIT covers interest
Current Ratio
1.70×
Short-term liquidity
Asset Turnover
1.24×
Revenue per ₹ of assets
Revenue CAGR (3Y)
7.9%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹40.86
Bear case
₹11.7
MoS -249.2%
Base case
₹19.8
MoS -106.4%
Bull case
₹25.21
MoS -62.1%
Ratio Trends
MEDICO · last 4 annual periods
ROE
16.2%
ROCE
22.5%
Operating Margin
—
Debt / Equity
0.24×
PE
86.0×
EV / EBITDA
39.1×
Historical Financials
MEDICO · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹118 Cr | ₹139 Cr | ₹143 Cr | ₹149 Cr | +7.9% |
| EBITDA | ₹11.4 Cr | ₹16.1 Cr | ₹14.9 Cr | ₹17.4 Cr | +15.0% |
| EBIT | — | ₹2.5 Cr | ₹4.5 Cr | — | +21.9% |
| PAT | ₹4.8 Cr | ₹7.2 Cr | ₹8.3 Cr | ₹10.1 Cr | +28.0% |
| EPS (diluted) | — | ₹0.21 | ₹0.37 | — | +20.8% |
| CFO | ₹5.9 Cr | ₹8.2 Cr | ₹2.4 Cr | ₹4.9 Cr | -5.9% |
| CapEx | ₹-5.9 Cr | — | — | ₹-3.2 Cr | — |
| FCF | ₹-0.1 Cr | — | — | ₹1.7 Cr | — |
| Total Assets | ₹77.4 Cr | ₹87.4 Cr | ₹96.2 Cr | ₹120 Cr | +15.7% |
| Total Debt | ₹12.6 Cr | ₹8.2 Cr | ₹7.2 Cr | ₹14.7 Cr | +5.3% |
| Shareholders' Equity | ₹36.6 Cr | ₹43.8 Cr | ₹52.4 Cr | ₹62.5 Cr | +19.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MEDICO vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| BAFNAPH BAFNA PHARMACEUTICALS LTD | -75.9% | 17 | Data Limited | 4.9% | — |
| MEDICAMEQ MEDICAMEQ | — | — | Pending | 3.3% | — |
| VALIANTLAB VALIANTLAB | — | — | Pending | -0.9% | — |
| ALBERTDAVD ALBERTDAVD | — | — | Pending | 4.4% | — |
| ZIMLAB ZIMLAB | — | — | Pending | 4.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for MEDICO in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. MEDICO REMEDIES LIMITED (MEDICO.NS) trades at 40.86 vs a model fair value of 19.80, a gap of -51.5%. Piotroski F-score: 5/9. Moat label: ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MEDICO →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MEDICO →
Compare
Head-to-head with peers
Compare MEDICO side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MEDICONow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.